Anika Therapeutics, Inc.

Anika Therapeutics (NASDAQ: ANIK - Get Free Report) and Xencor (NASDAQ: XNCR - Get Free Report) are both small-cap healthcare companies, but which is the better business? We will compare the two companies based on the strength of their analyst recommendations, institutional ownership, risk, profitability, valuation, dividends and earnings. Valuation and Earnings This table compares Anika Therapeutics

Corient Private Wealth LP bought a new stake in shares of Anika Therapeutics Inc. (NASDAQ: ANIK) during the undefined quarter, according to its most recent filing with the SEC. The firm bought 34,059 shares of the biotechnology company's stock, valued at approximately $498,000. Corient Private Wealth LP owned 0.25% of Anika Therapeutics as

Hsbc Holdings PLC purchased a new position in shares of Anika Therapeutics Inc. (NASDAQ: ANIK) during the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund purchased 50,105 shares of the biotechnology company's stock, valued at approximately $727,000. Hsbc Holdings PLC owned about 0.37% of

BTSG, ANIK and OPHC made it to the Zacks Rank #1 (Strong Buy) momentum stocks list on August 26th, 2026.